Women In Bio Announces Mary Thistle Joins Enterome’s Board of Directors
July 13 2017 - 8:00AM
Women In Bio (WIB), an organization of professionals committed to
promoting careers, leadership, and entrepreneurship of women in the
life sciences, announced today the fifth placement of a female
executive to a life sciences company board as part of its Boardroom
Ready program. WIB launched Boardroom Ready in 2016, with the
goal of helping executive women achieve corporate board service.
WIB is pleased to share that Mary Thistle, Chief Operating Officer
at Dimension Therapeutics, Inc. (NASDAQ:DMTX) has joined the Board
of Directors of Enterome SA, a pioneer of innovative therapies for
microbiome-related diseases, based in Paris, France and Cambridge,
MA. Ms. Thistle’s appointment marks the fifth successful placement
made by the program graduates in less than a year. LifeSci
Advisors, the founding sponsor of the Boardroom Ready program, has
also been instrumental in making several of these placements.
“I'm honored to serve on the Board of Directors of Enterome,
which has impressed me with its management team and promising
metagenomics platform identifying novel targets and biomarkers to
improve the diagnosis and management of serious diseases,” said Ms.
Thistle. “Enterome has been expanding rapidly and continues to make
steady progress advancing its pipeline. I believe these clinical
assets have potential in areas of high unmet need.”
Ms. Thistle is currently the Chief Operating Officer for
Dimension Therapeutics (NASDAQ:DMTX), a biopharmaceutical company
discovering and developing new therapeutic products for people
living with devastating rare and metabolic diseases associated with
the liver, based on the most advanced mammalian adeno-associated
virus (AAV) gene delivery technology. At Dimension, Ms. Thistle
played a significant role in successfully closing an oversubscribed
$65M series B round and introducing the company onto the NASDAQ
stock exchange in 2015. Ms. Thistle is a biopharmaceutical leader
with a 20+ year record in the life sciences industry, serving in
senior finance, operations, and business development roles.
Previously, Ms. Thistle was senior vice president, business
development at Cubist Pharmaceuticals where she was drove four
major acquisitions, including Trius Therapeutics and Optimer
Pharmaceuticals, significantly driving growth of the company’s
pipeline prior to Cubist’s recent $9.5 billion acquisition by
Merck. Earlier in her career, Ms. Thistle held leadership positions
ViaCell, Inc., ViaCell Reproductive Health, where she was
responsible for the expansion of the company’s ViaCord™ umbilical
blood-banking business and the eventual acquisition by PerkinElmer.
Ms. Thistle began her career in finance as a certified public
accountant working with both private and public companies.
“We could not be more impressed by the extensive knowledge base
and depth of experience of Boardroom Ready graduate Mary Thistle,”
said Dawn Hocevar, President, Women In Bio. “WIB is incredibly
proud to be hosting this executive program – now it its second year
– and we look forward to helping all of our Boardroom Ready
graduates make meaningful connections, with the goal of getting
placed on corporate boards and furthering gender equity in the
C-suite.”
The Boardroom Ready training class is held on an annual basis,
with applications accepted each spring. WIB’s Boardroom Ready
program is seeking qualified executive women to join our class of
candidates, sponsors, and coaches on an ongoing basis. If you
are aware of open board seats, please contact
boardroomready@womeninbio.org.
You can find out more information about Boardroom Ready and
Women In Bio’s commitment to board diversity by visiting:
http://womeninbio.org/executives/boardroom-ready.
Women In Bio (WIB) is an organization of
professionals committed to promoting careers, leadership, and
entrepreneurship of women in the life sciences. Each local chapter
hosts numerous events throughout the year, that vary from
networking events to career development, to professional education,
to executive level-focused events. In addition to events, WIB hosts
a mentorship program which offers women the chance to mentor or be
mentored, a Young Women In Bio program, which offers events and
encouragement to middle-school aged girls, webinars, and the
support of a large national organization with 13 chapters and
growing. As a volunteer organization, WIB offers leadership
opportunities at every stage of your career, and a chance to expand
your network in a supportive and professional environment. For more
information, visit www.womeninbio.org.
Contact: Stacie D. Byars, National Marketing Director, Women In Bio
Mobile: (206) 660-2588
E-mail: sbyars@womeninbio.org
DIMENSION THERAPEUTICS, INC. (NASDAQ:DMTX)
Historical Stock Chart
From Jan 2025 to Feb 2025
DIMENSION THERAPEUTICS, INC. (NASDAQ:DMTX)
Historical Stock Chart
From Feb 2024 to Feb 2025